Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Feb 24 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 9.18 | 6,200 | 56.92 k | 6,200 |
14 Feb 24 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 28,400 | 260.71 k | 28,400 |
3 Jan 24 | ONCT Oncternal Therapeutics | Common Stock | Payment of exercise | Dispose F | Yes | No | 0.4961 | 4,485 | 2.23 k | 15,426 |
3 Jan 24 | ONCT Oncternal Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.4961 | 50,955 | 25.28 k | 443,034 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 0.31 | 65,000 | 20.15 k | 65,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 0.31 | 12,500 | 3.88 k | 12,500 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 0.31 | 165,000 | 51.15 k | 165,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 0.31 | 2,000 | 620.00 | 2,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 0.31 | 7,000 | 2.17 k | 7,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 0.31 | 22,000 | 6.82 k | 12,240 |